![Shankar Musunuri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shankar Musunuri
Directeur Général chez
OCUGEN, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Shankar Musunuri was the founder of Nuron Biotech, Inc., founded in 2009, where the title held was President, Chief Executive Officer & Director in 2013.
Dr. Musunuri was the founder of Ocugen, Inc., founded in 2013, holding the title Chairman & Chief Executive Officer since 2023.
Dr. Musunuri is the founder of Ocugen OpCo, Inc., founded in 2013, holding the title Executive Chairman & Chief Executive Officer since 2015.
The current job is President & Secretary at OrthoCellix, Inc. Former jobs include Senior Director-Global Technology Transfer at Pfizer Inc. from 1996 to 2010, Principal at Wyeth LLC, and Principal at Amylin Pharmaceuticals, Inc. in 1996.
Education includes a doctorate from the University of Connecticut and an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUGEN INC 0,84 % | 20/04/2026 | 2 838 374 ( 0,84 % ) | 4 M $ | 31/05/2026 |
Postes actifs de Shankar Musunuri
| Sociétés | Poste | Début |
|---|---|---|
| OCUGEN, INC. | Directeur Général | 27/09/2019 |
Ocugen OpCo, Inc. | Directeur Général | 01/05/2015 |
Anciens postes connus de Shankar Musunuri
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/01/2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01/01/1996 |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Directeur Général | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Fondateur | - |
Formation de Shankar Musunuri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
